[HTML][HTML] Nanoparticle drug delivery systems designed to improve cancer vaccines and immunotherapy
Recent studies have demonstrated great therapeutic potential of educating and unleashing
our own immune system for cancer treatment. However, there are still major challenges in …
our own immune system for cancer treatment. However, there are still major challenges in …
Nanoparticle‐based nanomedicines to promote cancer immunotherapy: recent advances and future directions
Cancer immunotherapy is a promising cancer terminator by directing the patient's own
immune system in the fight against this challenging disorder. Despite the monumental …
immune system in the fight against this challenging disorder. Despite the monumental …
Nanoparticle systems for cancer vaccine
As effective tools for public health, vaccines prevent disease by priming the body's adaptive
and innate immune responses against an infection. Due to advances in understanding …
and innate immune responses against an infection. Due to advances in understanding …
Nanoparticle-based immunotherapy for cancer
The design of nanovaccines capable of triggering effective antitumor immunity requires an
understanding of how the immune system senses and responds to threats, including …
understanding of how the immune system senses and responds to threats, including …
Engineered nanoparticles for cancer vaccination and immunotherapy
Conspectus The immune system has evolved over time to protect the host from foreign
microorganisms. Activation of the immune system is predicated on a distinction between self …
microorganisms. Activation of the immune system is predicated on a distinction between self …
Nanoparticles for immune stimulation against infection, cancer, and autoimmunity
Vaccination using nanocarrier-based delivery systems has recently emerged as a promising
approach for meeting the continued challenge posed by infectious diseases and cancer. A …
approach for meeting the continued challenge posed by infectious diseases and cancer. A …
Nanoparticle‐based manipulation of antigen‐presenting cells for cancer immunotherapy
Immunotherapeutic approaches for treating cancer overall have been receiving a
considerable amount of interest due to the recent approval of several clinical formulations …
considerable amount of interest due to the recent approval of several clinical formulations …
Dendritic cell-based nanovaccines for cancer immunotherapy
Cancer immunotherapy critically relies on the efficient presentation of tumor antigens to T-
cells to elicit a potent anti-tumor immune response aimed at life-long protection against …
cells to elicit a potent anti-tumor immune response aimed at life-long protection against …
Recent advances in applying nanotechnologies for cancer immunotherapy
Cancer immunotherapy aimed at boosting cancer-specific immunoresponses to eradicate
tumor cells has evolved as a new treatment modality. Nanoparticles incorporating antigens …
tumor cells has evolved as a new treatment modality. Nanoparticles incorporating antigens …
Harnessing designed nanoparticles: Current strategies and future perspectives in cancer immunotherapy
Although cancer immunotherapy, represented by chimeric antigen receptor (CAR) T-cell
therapy and immune checkpoint-blockade therapies, has shown durable outcomes, the …
therapy and immune checkpoint-blockade therapies, has shown durable outcomes, the …